Clinical Trial Update: A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of (S)-Pindolol Benzoate (ACM-001.1) on lean body mass in obese patients, with PROACT 1 during obesity and PROACT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Sarcopenia

Drugs mentioned

• (S)-Pindolol Benzoate (ACM-001.1) (S-pindolol benzoate)

Snippet

Sponsor: Actimed Therapeutics Ltd | Conditions: Obesity, Muscle Loss | Phase 2 | Status: RECRUITING